APA (7th ed.) Citation

Alidjinou, E., Bocket, L., Pigot, V., Lambert, V., Hallaert, C., Canva, V., & Hober, D. (2018). Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients. Diagnostic Microbiology & Infectious Disease, 90(4), 277. https://doi.org/10.1016/j.diagmicrobio.2017.12.006

Chicago Style (17th ed.) Citation

Alidjinou, E.K, L. Bocket, V. Pigot, V. Lambert, C. Hallaert, V. Canva, and D. Hober. "Sanger Sequencing Versus INNO-LiPA® HBV PreCore Assay for Routine Detection of Precore and Basal Core Promoter Mutations in Hepatitis Virus B Chronically Infected Patients." Diagnostic Microbiology & Infectious Disease 90, no. 4 (2018): 277. https://doi.org/10.1016/j.diagmicrobio.2017.12.006.

MLA (9th ed.) Citation

Alidjinou, E.K, et al. "Sanger Sequencing Versus INNO-LiPA® HBV PreCore Assay for Routine Detection of Precore and Basal Core Promoter Mutations in Hepatitis Virus B Chronically Infected Patients." Diagnostic Microbiology & Infectious Disease, vol. 90, no. 4, 2018, p. 277, https://doi.org/10.1016/j.diagmicrobio.2017.12.006.